Anxiety disorders are a group of disorders that share symptoms like excessive fear and heightened stress (American Psychological Association [APA], 2022). It is important to note that fear and anxiety ...

NEW YORK--(BUSINESS WIRE)--Researchers from Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product ...

NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain ...

Please provide your email address to receive an email when new articles are posted on . Treatment of generalized anxiety disorder with an antidepressant increased the treatment response rate by 41%.

Individuals with generalized anxiety disorder (GAD), a condition characterized by daily excessive worry lasting at least six months, have a high relapse rate even after receiving treatment. Artificial ...

Generalized anxiety disorder affects 1 in 20 U.S. adults. Those with serious symptoms may isolate themselves to the point they rarely leave their home and are unable to work and build meaningful ...

Don’t panic — relief might be just one trip away. A mind-bending new study suggests a single dose of a psychedelic drug straight out of the Summer of Love could help ease symptoms in people with ...

Updating the treatment-scheduling process would make New York’s mental-health system more responsive, more modern and more effective.

Inc. has recently rebranded as Deinium Therapeutics Inc., is changing its Nasdaq ticker to DFTX, and outlined a late-stage ...

Findings highlight the link between anxiety severity and SI, underscoring the need for routine screening NEW YORK--(BUSINESS WIRE)-- Researchers from Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the ...